• A Case of Diffuse Scleroderma Presenting as Hypertensive Encephalopathy Due to Scleroderma Renal Crisis
• A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis
• A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale
• A rare form of calcinosis in patients with systemic sclerosis-myositis overlap: report of four cases
• Acute Respiratory Distress Syndrome in a Patient With Systemic Sclerosis: A Case of a Life-Threatening Complication
• Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis
• Application of cardiac magnetic resonance imaging in subclinical systemic sclerosis primary heart involvement
• Assessing hand and global disability in a cohort of Algerian patients with systemic sclerosis: Construct validities of the Arab Hand Function Index and the Arabic Health Assessment Questionnaire
• Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group
• Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis
• Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis
• Associations of Digital Ulcers in Patients with Systemic Sclerosis: An 8-Year Retrospective Study
• Autologous peripheral stem cell transplantation in systemic sclerosis: An important step forward, but we must temper our enthusiasm!
• Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial
• Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
• Case report of anti-survival motor neuron complex antibody-positive overlap syndrome of diffuse cutaneous systemic sclerosis and idiopathic inflammatory myopathies
• Causes and predictors of death among Finnish patients with systemic sclerosis
• Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort
• Characterization of kidneys in patients with systemic sclerosis by multi-parametric magnetic resonance quantitative imaging
• Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study
• Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients
• Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets
• Clinically Recognized Depression and Mental Health Treatment in a Single Center Cohort of Patients with Systemic Sclerosis
• Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression
• Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis
• Development and validation of a new diagnostic prediction model of ENHO and NOX4 for early diagnosis of systemic sclerosis
• Diffuse Large B-cell Lymphoma of the Ovaries Presenting With a Paraneoplastic Sclerotic Skin Lesion
• Diffuse systemic sclerosis managed with ayurvedic treatment modalities - A case report
• Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
• Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog
• Eosinophilic Pleural Effusion Secondary to Trichinella spiralis Infection in a Patient with Systemic Sclerosis: A Case Report
• Esophagus Dilation and Quality of Life in Adults with Scleroderma and Concomitant Obstructive Sleep Apnea
• Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis
• Exploratory clinical subgroup clustering in systemic sclerosis: Results from the Indian Progressive Systemic Sclerosis Registry
• Exploring the Utility of Circulating Endothelial Cell-Derived Extracellular Vesicles as Markers of Health and Damage of Vasal Endothelium in Systemic Sclerosis Patients Treated with Iloprost
• Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study
• Familial aggregation of diffuse cutaneous systemic sclerosis: Interplay of C1r gene defect, susceptible HLA haplotype and autoantibodies
• Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease
• Heart rate variability helps classify phenotype in systemic sclerosis
• High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis
• High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factors
• HLA Association among Thai Patients with Diffuse and Limited Cutaneous Systemic Sclerosis
• Human otopathology in scleroderma
• Imbalance of TH17/TREG cells in Tunisian patients with systemic sclerosis
• Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis
• Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity
• Insights into the Relationship between Periodontitis and Systemic Sclerosis Based on the New Periodontitis Classification (2018): A Cross-Sectional Study
• Interferon-γ Induces Interleukin-6 Production and Alpha-smooth Muscle Actin Expression in Systemic Sclerosis Fibroblasts
• Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index
• Late-age onset systemic sclerosis-clinical and serological characteristics
• Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients
• Macular choroidal thickness, volume, and vascularity index in patients with systemic sclerosis
• Minimal Detectable Changes of the HAQ-DI, PROMIS-29v2.0 Domains, and PHQ-8 in Systemic Sclerosis: A SPIN Cohort Cross-Sectional Study
• Nephrotic syndrome due to focal segmental glomerulosclerosis complicating scleroderma: a case report
• Nintedanib in systemic sclerosis treatment: a case report
• Nodular and diffuse spindle cell infiltration in keloidal scleroderma: a case report
• Nuclear-penetrating scleroderma autoantibody inhibits topoisomerase 1 cleavage complex formation
• Ocular Manifestation in Systemic Sclerosis-A Literature Review
• Ophthalmologic profile of patients with systemic sclerosis
• Optimizing Oral Immune Tolerance to Type II Collagen in Patients with Rheumatoid Arthritis: The Importance of Dose, Interfering Medication and Genetics
• Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up
• Outcomes of patients with diffuse systemic sclerosis eligible for autologous stem cell transplantation managed with conventional therapy
• Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy
• Overexpression of BAG3 (Bcl2-associated athanogene 3) in serum and skin of patients with systemic sclerosis
• Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation
• Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study
• Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis
• Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry
• Prevalence of the limited vs. extensive Scleroderma-interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysis
• Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysis
• Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis
• Pseudolymphomatous Cutaneous Angiosarcoma Presenting With Persistent Firm Facial Edema in a Patient With Systemic Sclerosis
• Resilience partially mediates the association between perceived social isolation and life satisfaction in people with systemic sclerosis
• Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
• Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study
• Scleroderma and Primary Myocardial Disease
• Scleroderma Associated With Organising Pneumonia and Polyarthritis: A Report of a Rare Case
• Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis
• Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding
• Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts
• Sexual dysfunction among female patients with rheumatic diseases
• Shear wave elastography-derived scoring system: application in the detection, subdivision and evaluation of systemic sclerosis
• Skin Ultrasound Assessment of Patients with Systemic Scleroderma-An Observational Study
• Sleep disorders and other medical and socio-demographic factors in systemic scleroderma
• Systemic sclerosis
• Systemic Sclerosis (Scleroderma)
• Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series
• Systemic sclerosis sine scleroderma: a time of re-appraisal
• Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal
• Systemic sclerosis: one year in review 2024
• Targeting CD13/aminopeptidase N as a novel therapeutic approach for scleroderma fibrosis
• Testing a candidate composite serum protein marker of skin severity in systemic sclerosis
• The arguments favoring autologous haematopoietic stem cell transplantation in systemic scleroderma
• The effect of systemic sclerosis and its subtypes on ocular anterior and posterior segment parameters
• The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis
• The Potential Effects of Diffuse Scleroderma in a Patient With Cervical Kyphosis
• The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review
• Thyroid Disorders in Systemic Sclerosis: A Comprehensive Review
• Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis
• Treatment Outcomes of Scleroderma With Janus Kinase Inhibitors: A Systematic Review